Cannabinoids for Treating Cardiovascular Disorders: Putting Together a Complex Puzzle.

Area of Science:

• Cardiovascular Pharmacology
• Endocannabinoid System Research

Background:

• Cannabinoids are increasingly recognized for potential therapeutic applications in cardiovascular disorders.
• Conditions include myocardial infarction, hypertension, atherosclerosis, arrhythmias, and metabolic disorders.

Purpose of the Study:

• To review the primary actions of cannabinoids on the cardiovascular system.
• To examine recent advances and major literature reviews in this field.

Main Methods:

• Literature review of studies on cannabinoid actions in cardiovascular disease.
• Examination of receptor-mediated effects (CB1 and CB2 receptors).

Main Results:

• Cannabinoid actions are mediated by cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors.
• Endocannabinoids induce a triphasic blood pressure response; synthetic cannabinoids show tissue/species specificity.
• Peripheral CB1 receptor blockade shows efficacy in cardiometabolic disorders.
• CB2 receptor blockade may aid atherosclerosis treatment by modulating immune cells.
• CB2 receptor activation shows promise in animal models of myocardial infarction and cardiac arrhythmia.

Conclusions:

• Cannabinoids demonstrate promising therapeutic potential for cardiovascular diseases in preclinical studies.
• Translating these findings to human clinical applications requires further extensive investigation.
• Clinical trials are essential to validate the efficacy and safety of cannabinoids for cardiovascular disease treatment.